Physician
Rachel Shoshana Levenbach, M.D.
According to 2025 Medicare claims, Rachel Levenbach, M.D. (NPI: 1902065857) practices hematology/oncology in the Camden, NJ market, with the plurality of this provider's patient population coming from Burlington, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 08057-3146.
Levenbach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 454 traditional Medicare patients, billed 80,310 HCPCS/CPT codes, and received $1,452,147 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 921 prescription claims across 231 beneficiaries totaling $1,297,906 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2018 DME data shows 11 claims. Open Payments data shows 2 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $403,154 to $1,452,147. Similarly, Part D prescription costs have risen steadily, from $159,631 to $1,297,906. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.